We conducted performance tests of three HBsAg ELISA diagnostic reagents using an Addcare 600 (Yantai Addcare Bio-tech Limited Company) and studied the consistency between the qualitative results and chemiluminescent microparticle immunoassay (CMIA) results.
| INTRODUCTION
Hepatitis B virus (HBV) infection is a public health problem of global concern. China is an area of high HBV incidence, and the hepatitis B surface antigen (HBsAg) carrier rate is 7.18%. Approximately 93 000 000 people carry HBV, and 10%-20% of cases of acute HBV will progress to chronic hepatitis every year, making disease prevention and control very arduous in China.
1,2 HBsAg was first discovered in 1965 and received considerable attention in studies of the natural progression of HBV infection the clinical efficacy of its treatments.
3,4
HBsAg serum level, one of the key indexes for diagnosing HBV infection, is related with viral DNA concentrations in the human body.
5,6
Therefore, HBsAg detection is very important in screening for HBV.
HBsAg detection methods range from the most traditional enzyme-linked immunosorbent assay (ELISA) to radioimmunoassay (RIA) and chemiluminescent microparticle immunoassay (CMIA) to electrochemiluminescence immunoassay (ECLIA), and the detection results are updated from qualitative to quantitative. [7] [8] [9] [10] However, due to its high sensitivity and specificity, low cost, and ease of use, especially for laboratories with limited resources, 11, 12 ELISA remains the most commonly used detection method in modern laboratory medicine.
Automatic ELISA analyzers can realize full automatic control using software to add the samples, perform the analysis, and interpret the results, which reduces accidental error of manual operation. They can also be used to perform multi-sample enzyme immunodetection assays and is superior to manual methods in terms of results stability, accuracy, and precision. 13 
| Positive serum and saline
Positive serum was taken from a patient for whom positive status was already confirmed at the Division of Liver Diseases, Shanxi Province
Academy of Traditional Chinese Medicine on September 20, 2014 with a concentration of 1 IU/mL detected by an ARCHITECT i2000 (Abbott, North Chicago, IL, USA) and diluted with saline for the C50 evaluation.
| Patient sera
Serum samples were collected from 1000 patients from the Division of Liver Diseases, Shanxi Province Academy of Traditional Chinese
Medicine between September 2014 and March 2015. All the samples were detected HBsAg by the ARCHITECT HBsAg quantitative determination kit. As a result, 690 cases of serum were positive and 310 cases were negative. Thousand serum samples were stored at −80°C until use.
| Instruments and reagents

| Instruments
Instruments used here include an Addcare 600 fully automatic ELISA analyzer, ARCHITECT i2000 automatic chemiluminescence immune apparatus (Abbott), and Multiskan III automatic microplate reader (Labsystems, Helsinki, Finland). 
| Reagents
| Methods
| Evaluation for intermediate precision
According were detected daily with 2-h interval between them, and the detections were performed continuously for 10 work days. The mean value of absorbance of samples/absorbance of cutoff (S/CO), standard deviation (SD), and coefficient of variation (CV; intermediate precision)
were calculated for batch-to-batch concentration levels.
| Repeatability evaluation
According to the EPl5-A (CLSI) files, the HBsAg quality control sera with concentrations of 0.2, 1, and 4 IU/mL were detected by the three HBsAg systems. Ten wells were used in one plate to calculate mean, SD, and CV (repeatability).
| C50 evaluation
According to User protocol for evaluation of qualitative test performance (EPl2-A2, CLSI), the collected HBsAg sample (1 IU/mL) was diluted by saline at 0.5% gradient decreases (99.5%, 99%, 98.5%, 
| Statistical analysis
| RESULTS
| Intermediate precision of the detecting system
Intermediate precision (CV) of the three detecting systems is shown in Table 2 .
Youden index = sensitivity + specificity − 1 T A B L E 3 Repeatability results for each detection system (n=10)
| Detection system repeatability
The repeatability (CV) of the detection system is shown in Table 3 .
| Detection system C50 estimation
The C5, C50, and C95 detection abilities of the three systems are shown in Table 4 .
| Comparison of the detection result for the three ELISA reagents and CMIA method
Six hundred and ninety positive serum samples were screened by CMIA and 310 samples were negative. In this experiment, the CMIA recheck sample was conformed as consistent via a neutralization test. The results of the three ELISA reagents are shown in Table 5 . 
| DISCUSSION
HBsAg status is often used to clinically evaluate treatment efficacy and prognosis of patients with HBV. As the most important serum marker for HBV, the accuracy of its detection is crucial. Among the various serological tests, ELISA is widely used due to its simplicity, rapid speed, and low cost. Moreover, the application of automatic Our results indicated that the intermediate precision and repeatability of each system were <14% and <9%, respectively, suggesting that they reached the performance index declared in the instructions and national standard (CV≤15%). The higher the quality control product concentration, the lower its intermediate precision and repeatability, a finding that was similar with the results of some studies on biochemical performance verification. 16 The detection results were increasingly more stable as HBsAg concentration increased. Besides, close to the weak positive value (0.2 IU/mL), the CV of S/CO increased. The intermediate precision and repeatability of B system was the lowest with the most stable result in the three reagents.
According to the method from EP12-A2, as long as the positive result reached 35%-65%, the sample's concentration was considered C50. The C50 values of the B and C systems were the lowest. C5, C50, and C95 of HBsAg detected by ELISA were reportedly 0.1, 0.15, and 0.2 IU/mL, 17 respectively, slightly higher than those in our study.
The possible reasons for the discrepancy are as follows: (i) the critical value of domestic HBsAg detection reagents increased as assay development progressed; and (ii) the combined application of reagents and the automatic analyzer.
For now, CMIA is an internationally used method with higher accuracy and specificity. 18 The total specificity and sensitivity of the ABBOTT test were 99.87% and 99.52% as described by the product specification of ABBOTT. To reduce the opportunity for false reactive and false-negative test results for the ABBOTT test which were used as a reference test, a total of 1000 serum samples were detected using a neutralization test. Due to the high price of imported confirmatory reagents, they have been not widely used in domestic laboratories.
Therefore, we chose a stable and reliable domestic HBsAg confirmatory reagent to perform the test on positive samples. Three ELISA systems were used to detect HBsAg in 1000 serum samples and the sensitivity and specificity had been calculated. Clinical specificity and sensitivity of an ideal diagnostic reagent should both be 100%, however, it is difficult to achieve this goal for one HBsAg ELISA system. The CE (Conformite Europeenne) guidelines require specificity of a CE test must be higher than 99.5%. The three ELISA kits are not CE certified but GMP (Good Manufacturing Practice) certified which did not put forward clear requirements to specificity and sensitivity. The results
showed that the sensitivity and specificity of the three systems were all high. That of Reagent B was the highest and was most close to the requirements of the CE guidelines, which was related with different techniques of coating monoclonal antibody in enzyme immunoassay microwell plate by different manufacturers. 19 When sensitivity and T A B L E 4 C50 estimation of each reagent (n=40; IU/mL) T A B L E 5 Results of Reagent A, B, C vs CMIA specificity were ofs equal importance, the Youden index was chosen to evaluate the comprehensive abilities of the reagent diagnosis.
20,21
The results showed that Reagent B possessed the highest Youden index, suggesting that its effect in the screening was the best with the highest authenticity and higher diagnostic value. The kappa value was the intrinsic efficacy index among the reagents which was used to assess the degree of agreement between two tests 22 and values of the three systems were all >0.95, indicating that in the detection of same people or samples in same batch, the results of the three systems were highly consistent with those of the CMIA method. Although the kappa value of reagent B was higher than those of reagents A and C, Wan-zhou et al. 23 reported that the diagnostic efficiency of reagent B was lower than those of A and C, a finding that was not in line with ours. The difference might be related to regional differences and sample size. Nevertheless, the possibility of false-negative and -positive rates in the detection of serum with low HBsAg level by ELISA method persists. Thus, confirmatory testing should also be used to clarify the diagnosis whenever necessary.
